Literature DB >> 16434179

Anesthetic management for cesarean delivery in a woman with Gilles de la Tourette's syndrome.

E B Sener1, S Kocamanoglu, E Ustun, A Tur.   

Abstract

Gilles de la Tourette's syndrome is a chronic neuropsychiatric disorder with an early childhood onset featuring mainly motor and vocal tics. We present the anesthetic management for cesarean delivery of a 21-year-old pregnant woman with Tourette's syndrome. She had shrugging of the shoulders and sudden, jerky, repetitive, irregular movements of the hands. General anesthesia was given for cesarean delivery. A live male infant weighing 3130 g was delivered. Her perioperative course was uneventful. No complication was observed. The patient and baby were discharged on the 4th postoperative day. It was decided to prescribe haloperidol 5 mg per day after lactation. Anesthesiologists should remember that there are special considerations when managing anesthesia in patients with Tourette's syndrome. The motor tics may lead to technical difficulty in performing regional anesthesia and surgery. Therefore general anesthesia may be appropriate in order to prevent agitation or involuntary movements. If patient movement and agitation can be controlled by sedation, regional block may be attempted. Drugs such as metoclopramide, ondansetron, midazolam and opioids may be used safely for anesthesia in Tourette's syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434179     DOI: 10.1016/j.ijoa.2005.07.004

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN: 0959-289X            Impact factor:   2.603


  2 in total

1.  Gilles de la Tourette syndrome in pregnancy: a retrospective series.

Authors:  J S Stern; M Orth; M M Robertson
Journal:  Obstet Med       Date:  2009-09-01

2.  Deep Brain Stimulation during Pregnancy and Delivery: Experience from a Series of "DBS Babies".

Authors:  Emma Scelzo; Jan H Mehrkens; Kai Bötzel; Paul Krack; Alexandre Mendes; Stéphan Chabardès; Mircea Polosan; Eric Seigneuret; Elena Moro; Valerie Fraix
Journal:  Front Neurol       Date:  2015-09-01       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.